• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Biden-Harris administration using taxpayer money to mask Medicare premium hikes before election: critics

by August 14, 2024
written by August 14, 2024

In a move critics say is designed to shield the Biden-Harris administration from election fallout, the administration has leveraged taxpayer funds to mask upcoming increases in Medicare premiums.

Under the Inflation Reduction Act (IRA), which was intended to cap out-of-pocket drug costs for Medicare beneficiaries, insurers are poised to significantly hike monthly premiums, with average bids for Part D plans expected to triple by 2025.

In response to potential voter backlash, the Centers for Medicare and Medicaid Services (CMS) rolled out a three-year ‘demonstration project’ to subsidize these premiums, aiming to keep them artificially low. However, despite the appearance of relief, some critics are saying that taxpayers will fund a dramatic increase in subsidies — from $30 per recipient per month in 2024 to $142.70 in 2025 — raising concerns about the long-term impact on government spending and debt. 

Former President Trump advisor Joe Grogan has criticized the maneuver, arguing that it merely shifts costs rather than providing real relief.

‘They’ve destroyed part D premiums,’ Grogan told Fox News Digital in an interview. ‘I’m not sure it’ll survive legal scrutiny if someone were to sue. Objectively, it shouldn’t be done. It’s just interjecting $5-10 billion of taxpayer dollars, while the taxpayers are paying the price 85 days before an election. It’s sickening.’

‘This is only going to get worse in 2025, 2026,’ Grogan continued. ‘The program is in a death spiral. They announced a three-year demo. It’s already broken. The demo is going to fail. Premiums are still going to go up.’

Paragon Health Institute, a health care research group, called the CMS demo plan a ‘fake, costly demonstration,’ in a recent analysis. 

‘Fearing the premium increases that the IRA redesign will impose on Part D plans, CMS has now launched a new voluntary, nationwide demonstration program that is neither a demonstration nor voluntary. Unlike this massive subsidization scheme, demonstrations are supposed to be limited in nature and test alternative features of program design,’ the institute wrote. ‘As a result of the IRA changes, insurers that don’t participate are expected to either be uncompetitive from a price perspective or face significant losses – hardly a choice for insurers.’

Research published by Fidelity, an investment research group, shows that a 65-year-old retiring today can expect to spend $165,000 on health care in retirement, a 5% increase from last year and more than double the estimate from 2002.

Yet, there appears to be a disconnect for many Americans between the actual projected cost of health care in retirement and how much they expect to spend on those expenses. The average American thinks they will spend about $75,000 on health care and other medical expenses, less than half of Fidelity’s calculation, according to the research.

The estimate assumes that an individual is enrolled in Medicare – including Part A and Part B, which cover most hospital care and doctor’s visits – and Part D, which covers prescription drugs. Other expenses such as Medicare premiums, over-the-counter medications, dental and vision care and other costs typically not covered by Medicare are ‘left to retirees to manage on their own,’ the report said.

As of April 2024, about 67.3 million Americans were enrolled in Medicare, according to the Centers for Medicare and Medicaid Services. Of those, about half were enrolled in a Medicare Advantage plan, while about 80% were covered by Medicare Part D.

‘They just want to get through the election,’ Grogan said. ‘They’re hoping after the election they can face it, but its gonna need to be dealt with in the next 12–18 months. They did not believe it would be this bad and its only gonna get worse.’ 

Americans are also dealing with a spike in the cost of prescription drugs, which has surged nearly 40% over the past decade, easily outstripping the pace of inflation. 

Fox News Digital has reached out to CMS for comment. 

Fox Business’ Megan Henney contributed to this report. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Oil and natural gas: oil price in retreat since Tuesday
next post
The dollar index under strong bearish pressure this week

related articles

Former Iranian prisoners reveal torture horrors as regime...

January 17, 2026

Trump announces escalating tariffs on Denmark and other...

January 17, 2026

Democrat insider rips Mamdani bidet hopes for Gracie...

January 17, 2026

Khamenei calls Trump a ‘criminal,’ blames him for...

January 17, 2026

NATO ambassador says Europe ‘has a tendency to...

January 17, 2026

Trump credits halted Iran executions for delaying military...

January 16, 2026

Hunter Biden accused of ghosting daughter with Lunden...

January 16, 2026

Trump says $50B rural health plan funded by...

January 16, 2026

Machado issues warning on Maduro successor as Trump...

January 16, 2026

CIA director was in Venezuela to meet with...

January 16, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Musk boasts of 1B views for ‘no limits’ X interview with Trump

    August 13, 2024
  • Waymo offers teen accounts for driverless rides

    July 8, 2025
  • Tight-lipped House Dems still divided on Biden, leave closed-door meeting without consensus

    July 10, 2024
  • IBIT and the Evolution of Spot Bitcoin ETFs

    August 21, 2024
  • Democratic socialists torch AOC for voting against Republican anti-Israel amendment

    July 21, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (7,519)
  • Investing (834)
  • Stock (966)

Latest Posts

  • U.S. judge orders Google to share search data with competitors

    September 3, 2025
  • Barclays settles $17.7 billion debt sale lawsuit for $19.5 million amid securities fraud claims

    December 4, 2024
  • Trump cuts off federal resources for law firm that helped fuel 2016 Russia hoax

    March 7, 2025

Recent Posts

  • Times Square billboard pops up rallying around ‘historic’ Trump accomplishment during first 100 days

    April 28, 2025
  • Senate Republicans plan hearing on Biden’s alleged cognitive decline cover-up

    May 29, 2025
  • AMD: AI Portfolio with $4.9B Cash

    August 20, 2024

Editor’s Pick

  • Dems delay Patel committee vote, deride Trump FBI pick as danger to US security

    February 6, 2025
  • Walmart boosts sales outlook as it says tariff costs are rising

    August 21, 2025
  • Biden ‘Politburo’ member Steve Ricchetti to appear before House investigators in Comer cover-up probe

    July 30, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock